Showing results (551-560 of 667) with videos related to
Sort By:
Pageof 67
Geophysical Research Letters|January 13, 2018
New Antarctic Gravity Anomaly Grid for Enhanced Geodetic and Geophysical Studies in AntarcticaM Scheinert, F Ferraccioli, J Schwabe, et al.Frontiers in Pharmacology|February 15, 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML PatientTorsten H Nielsen, Nathalie Johnson, Nicolas Garnier, et al.Genes & Development|August 26, 2017
Histone locus regulation by the Drosophila dosage compensation adaptor protein CLAMPLeila E Rieder, Kaitlin P Koreski, Kara A Boltz, et al.Blood Advances|April 21, 2020
Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progressionZachary J Walker, Michael J VanWyngarden, Brett M Stevens, et al.Blood|January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetSaman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.Journal of Epidemiology and Global Health|July 17, 2013
Putting surveillance data into context: the role of health care utilization surveys in understanding population burden of pneumonia in developing countriesMeredith Deutscher, Chris Van Beneden, Deron Burton, et al.Diabetes Care|December 3, 2020
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 DiabetesJustin M Gregory, James C Slaughter, Sara H Duffus, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.Molecular Cancer Therapeutics|June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemiaMonica L Guzman, Neng Yang, Krishan K Sharma, et al.Neurology|April 26, 2020
Attracting neurology's next generation: A qualitative study of specialty choice and perceptionsJustin T Jordan, Carolyn Cahill, Tasha Ostendorf, et al.Pageof 67